A Win For Lineage Cell Therapeutics, Inc.
Mon, Apr 12, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) rocketted at $7.91, a gain of 23%. On Fri, Apr 09, 2021, BTX:NYSEMKT hit a New 2-Week High of $6.43. The stock appeared on our News Catalysts scanner on Thu, Apr 01, 2021 at 09:59 AM in the 'MERGER' category. From Fri, Mar 26, 2021, the stock recorded 44.44% Up Days and 30.00% Green Days
The stock spiked on Tue, Apr 06, 2021 at $8.53 with a volume of 44M+.
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- Celcuity Inc. (CELC:NASDAQ), 29.35%
- LHDX (LHDX:NASDAQ), 27.01%
- Wilhelmina International, Inc. (WHLM:NASDAQ), 25.18%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 23.02%
- ATNF (ATNF:NASDAQ), 23%
- PLBY (PLBY:NASDAQ), 19.89%
- Pintec Technology Holdings Limited (PT:NASDAQ), 18.03%
- TSHA (TSHA:NASDAQ), 17.98%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 17.98%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 17.73%